Semaglutide

Mechanism: Semaglutide targets localized GLP-1 pathways to alter hindbrain appetite messaging vectors and reduce fasting glucagon release.

Sequence: HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG

Recommended Dosage: Commences at 0.25mg once weekly for 4 weeks. Titrates up through 0.5mg, 1.0mg, and 1.7mg, settling at a peak maintenance dose of 2.4mg weekly.

Tracking Cycle: Long-term tracking models span 16 to 52 weeks.